No profile data available.
Globus Medical, Inc. (GMED) is a healthcare company in the bone and joint treatment equipment industry, based in Audubon, United States, with about 6,000 full-time employees.
It reported revenue of $2.94 billion for fiscal year 2025, up 16.7% from fiscal year 2024, and net income of $537.87 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $789.61 million, up 5.9% from a year before. United States was its largest region in fiscal year 2025, with 81% of revenue. Its market capitalization was $10.02 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
Globus Medical reported $2.94 billion in revenue for fiscal year 2025, up 16.7% from $2.52 billion in fiscal year 2024. In Q2 2026 revenue was $789.61 million.
United States: 81% of revenue by region in fiscal year 2025, followed by International (19%).
$10.02 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (bone and joint treatment equipment) include Zimmer Biomet Holdings, Inc. (ZBH), Smith & Nephew plc (SNN), Vericel Corporation (VCEL), Alphatec Holdings, Inc. (ATEC).